30 results on '"Young, Brandon M."'
Search Results
2. Sonic Hedgehog activates prostaglandin signaling to stabilize primary cilium length
3. Structure and mechanism of Staphylococcus aureus oleate hydratase (OhyA)
4. The role of ZA channel water-mediated interactions in the design of bromodomain-selective BET inhibitors
5. Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors
6. Modulation of p47 PHOX Activity by Site-Specific Phosphorylation: Akt-Dependent Activation of the NADPH Oxidase
7. Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer
8. Supplementary Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer
9. Figure S4 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial
10. Supplementary Tables S1-S8 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial
11. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement
12. Morphogen Directed Coordination of GPCR Activity Promotes Primary Cilium Function for Downstream Signaling
13. Expression Quantitative Trait Loci Mapping Identifies New Genetic Models of Glutathione S-Transferase Variation
14. Synthesis of Isotopically Labeled, Spin-Isolated Tyrosine and Phenylalanine for Protein NMR Applications
15. Modulation of [p47.sup.PHOX] activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase
16. Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer
17. An Integrated, Optofluidic System With Aligned Optical Waveguides, Microlenses, and Coupling Prisms for Fluorescence Sensing
18. A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial
19. RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue
20. Abstract 5794: Targeting the BD2 BET bromodomain to inhibit proliferation of pancreatic ductal adenocarcinoma cells
21. High expression of FGD3, a putative regulator of cell morphology and motility, is prognostic of favorable outcome in multiple cancers
22. Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.
23. Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab
24. Abstract 2123: Antibody-dependent cell-mediated cytotoxicity (ADCC) tolerance to monoclonal antibody therapeutics in human breast and colon cancer cell lines
25. Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents
26. Abstract P2-05-14: New treatment options for metastatic breast cancer revealed by reverse-phase protein microarray and genomic profiling
27. Abstract 261: Emerging roles for the CREB regulated transcription coactivators (CRTCs) in oncogenesis
28. Structure−Activity Relationships of Substituted 1-Pyridyl-2-phenyl-1,2-ethanediones: Potent, Selective Carboxylesterase Inhibitors
29. Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents.
30. Modulation of p47PHOXactivity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.